Merck KGaA Profit Beats Estimates on Cost-Cutting

May 14 (Bloomberg) -- Merck KGaA, the German maker of cancer drug Erbitux, said first-quarter profit rose on higher-than-expected savings from a reorganization program, and forecast it will achieve 2014 targets a year ahead of schedule. Mark Barton reports on Bloomberg Television's "Countdown." (Source: Bloomberg)
Hacker Teen Uses 'Swatting' to Harass Online Gamers
54:31 - Bloomberg's Emily Chang reports on the teenage hacker who admitted to "swatting" online gamers. She speaks on "Bloomberg West." (Source: Bloomberg)
  • How Close Are We to an Uber IPO?
  • The Top Three Things to Watch for at Google I/O
  • U.S. Economy Set Up for Sept. or Oct. Rate Hike: Kleintop